ParkerVision, Inc.'s SEC filings document an OTCQB-traded Florida corporation focused on proprietary RF technologies, wireless applications, licensing, and patent enforcement. Its 8-K filings report operating results, legal and appellate developments involving patent claims, and material events that affect the company's capital structure and disclosure record.
The filing record also covers registered direct common stock offerings under a Form S-3 shelf registration statement, exchanges of convertible promissory notes for common stock, unregistered equity issuance disclosures, and executive compensation arrangements under the company's long-term incentive plan. These documents address governance approvals, share-based awards, financing terms, and risk references tied to patent proceedings and funding activity.
ParkerVision, Inc. appointed William G. Walters as a Class II director on October 23, 2026, filling a vacancy after the board expanded from four to five members. Walters, age 89, is retired from an investment banking career focused on micro- and small-cap companies. The accompanying announcement says his career included raising over $3 billion and multiple IPOs. He will receive ParkerVision's standard non-employee director compensation, and the company entered into its standard indemnification agreement with him.
ParkerVision, Inc. is updating a prospectus that permits selling shareholders to resell up to 9,387,500 shares of common stock.
The resale amount comprises 2,843,750 shares already issued under securities purchase agreements, 6,343,750 shares tied to conversion of convertible notes and interest payments at ParkerVision’s option, and 200,000 shares issuable upon exercise of options issued as payment for services. ParkerVision will not receive proceeds from selling shareholders’ resales. If the options are exercised for cash, ParkerVision could receive up to $42,620 in gross proceeds, which it expects to use for general working capital.
ParkerVision, Inc. (PRKR) has a prospectus permitting selling shareholders to resell up to 16,638,353 shares of common stock. The shares are issuable upon conversion of, and for payment of interest from time to time at ParkerVision’s option for, convertible promissory notes dated between May 10, 2022 and August 3, 2022; the notes have a fixed conversion price of $0.13 per share.
The supplement updates the existing prospectus with information from a current report. ParkerVision stated that the report announces the Federal Circuit issued an order in the expedited appeal of its patent infringement case against Qualcomm. ParkerVision also states that these Form 424B3 updates do not involve issuance of new securities.
ParkerVision, Inc. (PRKR) has a prospectus permitting the selling stockholder to resell up to 1,578,946 shares of common stock, comprising 1,052,631 shares of common stock and 526,315 shares underlying warrants. ParkerVision will not receive proceeds from resales. To the extent the warrants are exercised for cash, ParkerVision will receive up to $526,315 in gross proceeds, which it expects to use for general working capital, including litigation expenses.
ParkerVision also reported that the Court of Appeals for the Federal Circuit issued its order in the expedited appeal of the company’s patent infringement case against Qualcomm. The company stated that its Form 424B3 updates typically do not involve the issuance of new securities.
ParkerVision, Inc. updates its resale prospectus, which permits selling stockholders to resell up to 13,342,953 shares of common stock. The registered amount comprises 7,962,722 shares issued under securities purchase agreements, 3,230,942 shares issued under a March 29, 2021 agreement, 1,619,289 shares underlying warrants issued under that agreement, and 530,000 shares issued as payment for services.
ParkerVision will receive no proceeds from stockholder resales. If the warrants are exercised for cash, ParkerVision may receive up to $2,833,756 in gross proceeds and expects to use any proceeds received for general working capital, including payment of litigation expenses.
ParkerVision, Inc. (PRKR) is supplementing a resale prospectus that permits selling stockholders to resell up to 5,871,584 shares of common stock. The shares were issued under securities purchase agreements, and ParkerVision says it will receive no proceeds from the selling stockholders’ sales.
The attached 8-K reports that the Court of Appeals for the Federal Circuit issued an order in the expedited appeal of ParkerVision’s patent infringement case against Qualcomm. ParkerVision also says it will file Form 424B3 supplements to maintain the effectiveness of previously filed S-1 registration statements; it says those filings do not involve new securities issuance.
ParkerVision’s prospectus permits selling stockholders to resell up to 16,809,295 shares of common stock. The shares include up to 4,961,538 issuable upon conversion of convertible notes and for interest payments at ParkerVision’s option; 3,907,331 issued under securities purchase agreements; 2,740,426 issued for services and repayment of short-term loans and other payables; and warrant shares: up to 5,000,000 at $0.74 per share and up to 200,000 at $1.00 per share.
ParkerVision receives no proceeds from resales. Cash exercise of the Aspire and Tailwinds warrants could generate up to $3,900,000 in gross proceeds, which ParkerVision expects to use for general working capital and corporate purposes. Separately, ParkerVision disclosed that the Court of Appeals for the Federal Circuit issued an order on October 1, 2026, in the expedited appeal of its patent infringement case against Qualcomm.
ParkerVision, Inc. describes a resale by selling stockholders of up to 18,014,164 shares of its common stock. The shares include up to 5,457,583 shares issuable under the Tranche 1 Notes, up to 10,131,581 shares issuable under the Tranche 2 Notes, 625,000 shares issued for consulting services, and up to 1,800,000 shares issuable upon exercise of the Park Consulting Warrant. The notes have fixed conversion prices of $0.10 and $0.08 per share, respectively; the warrant has a $0.10 exercise price.
ParkerVision will not receive proceeds from selling stockholders’ resales. If the warrant is exercised for cash, ParkerVision could receive up to $180,000 in gross proceeds, expected to be used for general working capital and corporate purposes. ParkerVision also reported that the Court of Appeals for the Federal Circuit issued an order in the expedited appeal of its patent infringement case against Qualcomm.
ParkerVision, Inc. (PRKR) continues to permit selling stockholders to resell up to 17,189,660 shares of common stock under its April 19, 2019 prospectus. This supplement updates that prospectus with an October 1, 2026 Form 8-K; ParkerVision says its Form 424B3 updates maintain previously filed registration statements and do not involve issuance of new securities.
The resale amount includes 1,273,540 shares from a 2016 private placement and warrant, including up to 350,000 warrant shares at an exercise price of $2 per share; up to 10,000,000 shares issued or issuable to Aspire Capital under a 2018 agreement; and 5,916,120 shares issuable upon conversion of, or for interest on, 2018 notes with fixed conversion prices of $0.40 and $0.57 per share. ParkerVision says it receives no proceeds from selling-stockholder sales, but could receive up to $700,000 gross from cash exercise of the 2016 Warrant and may receive up to an additional $1,763,500 from common-stock sales or exercise of Aspire Capital warrants. The Form 8-K reports that the Federal Circuit issued an order in the expedited appeal of ParkerVision’s patent infringement case against Qualcomm.
ParkerVision, Inc. (PRKR) permits selling stockholders to resell up to 12,800,000 shares of common stock. The amount includes up to 7,800,000 shares issuable in connection with convertible promissory notes and 5,000,000 shares issuable upon exercise of a five-year warrant.
ParkerVision receives no proceeds from sales by selling stockholders. If the warrant is exercised for cash, ParkerVision may receive up to an aggregate of $800,000 in gross proceeds, which it expects to use for patent enforcement actions, working capital and general corporate purposes. The company also reported that the Court of Appeals for the Federal Circuit issued its order in the expedited appeal of its patent infringement case against Qualcomm.